£110.00

Springer Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

White

Price data last checked 47 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 44 days • 44 data points (No recent data available)

Historical
Generating forecast...
£140.72 £106.93 £114.30 £121.67 £129.05 £136.42 £143.79 25 January 2026 04 February 2026 15 February 2026 26 February 2026 09 March 2026

Price Distribution

Price distribution over 44 days • 2 price levels

Days at Price
Current Price
1 day · current 43 days 0 11 22 32 43 £110 £141 Days at Price

Price Analysis

Most common price: £141 (43 days, 97.7%)

Price range: £110 - £141

Price levels: 2 different prices over 44 days

Description

Product Description This book offers a comprehensive introduction to translational efforts in breast cancer, addressing the latest approaches to precision medicine based on the current state of understanding of breast cancer.  With the latest developments in breast cancer research, our understanding of the genomic changes and the oncogenic signaling cascade of breast cancer has made considerable strides. Further, the immuno-environment has been demonstrated as the barrier to clinical cancer.   In addition, major advances in cancer biology, immunology, genomics and metabolism have broken new ground for designing therapeutic approaches and selecting appropriate treatments on the basis of more precise information on the individual patient.   As a result of these two trends, a clearer picture of the molecular landscape of breast cancers has facilitated the development of diagnostic, prognostic and predictive biomarkers for clinical oncology. All these aspects are addressed in this volume, which offers a comprehensive resource for researchers, graduate students and oncologists in cancer research.   From the Back Cover This book offers a comprehensive introduction to translational efforts in breast cancer, addressing the latest approaches to precision medicine based on the current state of understanding of breast cancer.   With the latest developments in breast cancer research, our understanding of the genomic changes and the oncogenic signaling cascade of breast cancer has made considerable strides. Further, the immuno-environment has been demonstrated as the barrier to clinical cancer.     As a result of these two trends, a clearer picture of the molecular landscape of breast cancers has facilitated the development of diagnostic, prognostic and predictive biomarkers for clinical oncology. All these aspects are addressed in this volume, which offers a comprehensive resource for researchers, graduate students and oncologists in cancer research.   About the Author Dr. Erwei Song and Dr. Hai Hu are both Professors at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

Product Specifications

Colour
White
Format
hardcover
Domain
Amazon UK
Release Date
30 January 2018
Listed Since
29 June 2017

Barcode

No barcode data available